Should My Patient Accept a Kidney from a Hepatitis C Virus-Infected Donor?
作者信息
Pagan Javier, Ladino Marco, Roth David
机构信息
Katz Family Division of Nephrology and Hypertension, University of Miami Miller School of Medicine, Miami, Florida; and.
Nephrology Section, Miami Veterans Administration Healthcare System, Miami, Florida.
出版信息
Kidney360. 2020 Jan 15;1(2):127-129. doi: 10.34067/KID.0001012019. eCollection 2020 Feb 27.
Abstract
摘要
相似文献
1
Should My Patient Accept a Kidney from a Hepatitis C Virus-Infected Donor?我的患者应该接受来自丙型肝炎病毒感染供体的肾脏吗？
Kidney360. 2020 Jan 15;1(2):127-129. doi: 10.34067/KID.0001012019. eCollection 2020 Feb 27.
2
Re: Impact of Donor Hepatitis C Virus on Kidney Transplant Outcomes for Hepatitis C-Positive Recipients in the Direct-Acting Antiviral Era: Time to Revise the Kidney Donor Risk Index?关于：在直接抗病毒药物时代，供体丙型肝炎病毒对丙型肝炎病毒阳性受者肾移植结局的影响：是时候修订肾脏供体风险指数了吗？
J Urol. 2020 Dec;204(6):1369. doi: 10.1097/JU.0000000000001277. Epub 2020 Sep 21.
3
A review of kidney transplantation from HCV-viremic donors into HCV-negative recipients.丙型肝炎病毒血症供体至丙型肝炎病毒阴性受体的肾移植综述。
Kidney Int. 2021 Dec;100(6):1190-1198. doi: 10.1016/j.kint.2021.06.034. Epub 2021 Jul 6.
4
Exploring patient willingness to accept hepatitis C-infected kidneys for transplantation.探讨患者对接受丙型肝炎感染肾脏进行移植的意愿。
BMC Nephrol. 2020 Nov 10;21(1):473. doi: 10.1186/s12882-020-02114-y.
5
Hepatitis C virus and nonliver solid organ transplantation.丙型肝炎病毒与非肝脏实体器官移植。
Transplantation. 2013 Mar 27;95(6):779-86. doi: 10.1097/TP.0b013e318273fec4.
6
Temporal trends and impact of willingness to accept organs from donors with hepatitis C virus.愿意接受丙型肝炎病毒供体器官的意愿的时间趋势和影响。
Transpl Int. 2021 Dec;34(12):2562-2569. doi: 10.1111/tri.14152. Epub 2021 Nov 11.
7
Kidney transplantation and waitlist mortality rates among candidates registered as willing to accept a hepatitis C infected kidney.登记愿意接受丙型肝炎感染肾脏的候选者中的肾移植及等待名单死亡率。
Transpl Infect Dis. 2018 Apr;20(2):e12829. doi: 10.1111/tid.12829. Epub 2018 Jan 25.
8
Lessons from the real world: HCV-infected donor kidney transplantation as standard practice.来自现实世界的经验教训：丙型肝炎病毒感染供体肾移植作为标准做法。
Am J Transplant. 2019 Nov;19(11):2969-2970. doi: 10.1111/ajt.15582. Epub 2019 Oct 8.
9
Hepatitis C-Positive Donors in Cardiac Transplantation: Problems and Opportunities.丙型肝炎阳性供体在心脏移植中的问题与机遇。
Curr Heart Fail Rep. 2020 Aug;17(4):106-115. doi: 10.1007/s11897-020-00466-y.
10
Transplanting Kidney Allografts from Hepatitis C Infected Donors into Hepatitis C Uninfected Recipients: Re-Thinking the Thinker Trial.将丙型肝炎感染供体的肾移植到丙型肝炎未感染受者中：重新思考 Thinker 试验。
Ann Hepatol. 2017 Sep-Oct;16(5):702-703. doi: 10.5604/01.3001.0010.2708.
引用本文的文献
1
Use of Hepatitis C Virus Antibody-Positive Donors in Kidney Transplantation.丙型肝炎病毒抗体阳性供体在肾移植中的应用。
Cureus. 2024 Jan 8;16(1):e51849. doi: 10.7759/cureus.51849. eCollection 2024 Jan.
本文引用的文献
1
Hepatitis C Virus NAT-Positive Solid Organ Allografts Transplanted Into Hepatitis C Virus-Negative Recipients: A Real-World Experience.丙型肝炎病毒核酸检测阳性的实体器官移植物移植到丙型肝炎病毒阴性受者：真实世界的经验。
Hepatology. 2020 Jul;72(1):32-41. doi: 10.1002/hep.31011. Epub 2020 Apr 15.
2
Hepatitis C Virus Positivity Should Not Be Included in the Kidney Donor Profile Index Calculation When Transplanting HCV-Positive Kidneys Into Noninfected Recipients in the Era of Direct-Acting Antiviral Agents.在直接抗病毒药物时代，将丙型肝炎病毒（HCV）阳性肾脏移植给未感染的受者时，丙型肝炎病毒阳性不应纳入肾脏供体概况指数的计算。
Prog Transplant. 2019 Dec;29(4):371-372. doi: 10.1177/1526924819874373. Epub 2019 Sep 18.
3
Fibrosing cholestatic hepatitis after kidney transplantation from HCV-viremic donors to HCV-negative recipients: A unique complication in the DAA era.肝纤维化性胆汁淤积性肝炎在 HCV 病毒血症供者至 HCV 阴性受者的肾移植后发生：DAA 时代的一个独特并发症。
Am J Transplant. 2020 Feb;20(2):600-605. doi: 10.1111/ajt.15583. Epub 2019 Sep 18.
4
Transplantation of kidneys from hepatitis C-infected donors to hepatitis C-negative recipients: Single center experience.从丙型肝炎感染供体向丙型肝炎阴性受者移植肾脏：单中心经验。
Am J Transplant. 2019 Nov;19(11):3046-3057. doi: 10.1111/ajt.15530. Epub 2019 Aug 2.
5
Treating hepatitis C virus in dialysis patients: How, when, and why?透析患者丙型肝炎病毒的治疗：如何治疗、何时治疗以及为何治疗？
Semin Dial. 2019 Mar;32(2):152-158. doi: 10.1111/sdi.12764. Epub 2018 Nov 26.
6
Twelve-Month Outcomes After Transplant of Hepatitis C-Infected Kidneys Into Uninfected Recipients: A Single-Group Trial.感染 HCV 的供肾移植至未感染受者后 12 个月的结果：单组试验。
Ann Intern Med. 2018 Sep 4;169(5):273-281. doi: 10.7326/M18-0749. Epub 2018 Aug 7.
7
Should organs from hepatitis C-positive donors be used in hepatitis C-negative recipients for liver transplantation?丙型肝炎病毒阳性供者的器官是否应用于丙型肝炎病毒阴性受者的肝移植？
Liver Transpl. 2018 Jun;24(6):831-840. doi: 10.1002/lt.25072.
8
Direct-Acting Antiviral Prophylaxis in Kidney Transplantation From Hepatitis C Virus-Infected Donors to Noninfected Recipients: An Open-Label Nonrandomized Trial.直接作用抗病毒预防在丙型肝炎病毒感染供体向非感染受者的肾移植中的应用：一项开放标签非随机试验。
Ann Intern Med. 2018 Apr 17;168(8):533-540. doi: 10.7326/M17-2871. Epub 2018 Mar 6.
9
Transplantation of kidneys from hepatitis C-positive donors into hepatitis C virus-infected recipients followed by early initiation of direct acting antiviral therapy: a single-center retrospective study.丙型肝炎病毒阳性供者肾移植术后早期应用直接抗病毒药物治疗丙型肝炎病毒感染受者:单中心回顾性研究。
Transpl Int. 2017 Sep;30(9):865-873. doi: 10.1111/tri.12954. Epub 2017 May 2.
10
Safety and Efficacy of Treatment of Hepatitis C in Kidney Transplant Recipients With Directly Acting Antiviral Agents.直接作用抗病毒药物治疗肾移植受者丙型肝炎的安全性和疗效。
Transplantation. 2017 Jul;101(7):1704-1710. doi: 10.1097/TP.0000000000001618.
Zotero 插件